192 related articles for article (PubMed ID: 35500377)
1. Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation.
Shimoda Y; Murakoshi N; Mori H; Xu D; Tajiri K; Hemmi Y; Sato I; Noguchi M; Nakamura Y; Hayashi Y; Ieda M
Stem Cell Res; 2022 Jul; 62():102793. PubMed ID: 35500377
[TBL] [Abstract][Full Text] [Related]
2. Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells.
Lee YK; Lau YM; Cai ZJ; Lai WH; Wong LY; Tse HF; Ng KM; Siu CW
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28754655
[TBL] [Abstract][Full Text] [Related]
3. Investigating
Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
[No Abstract] [Full Text] [Related]
4. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
[TBL] [Abstract][Full Text] [Related]
5. Modeling of
Shah D; Virtanen L; Prajapati C; Kiamehr M; Gullmets J; West G; Kreutzer J; Pekkanen-Mattila M; Heliö T; Kallio P; Taimen P; Aalto-Setälä K
Cells; 2019 Jun; 8(6):. PubMed ID: 31208058
[TBL] [Abstract][Full Text] [Related]
6. Generation of an iPSC cell line (USFi003-A) from a patient with dilated cardiomyopathy carrying a heterozygous mutation in LMNA (p.R541C).
Yang J; Burgos Angulo M; Argenziano MA; Bertalovitz A; Najari Beidokhti M; McDonald TV
Stem Cell Res; 2021 Jul; 54():102396. PubMed ID: 34029931
[TBL] [Abstract][Full Text] [Related]
7. Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation.
Cattelan G; Sophie Frommelt L; Volani C; Colliva A; Ciucci G; Paldino A; Dal Ferro M; Di Segni M; Silipigni R; Pramstaller PP; De Bortoli M; Zacchigna S; Rossini A
Stem Cell Res; 2023 Sep; 71():103172. PubMed ID: 37535990
[TBL] [Abstract][Full Text] [Related]
8. Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy.
Lee J; Termglinchan V; Diecke S; Itzhaki I; Lam CK; Garg P; Lau E; Greenhaw M; Seeger T; Wu H; Zhang JZ; Chen X; Gil IP; Ameen M; Sallam K; Rhee JW; Churko JM; Chaudhary R; Chour T; Wang PJ; Snyder MP; Chang HY; Karakikes I; Wu JC
Nature; 2019 Aug; 572(7769):335-340. PubMed ID: 31316208
[TBL] [Abstract][Full Text] [Related]
9. Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death.
Yokokawa T; Ichimura S; Hijioka N; Kaneshiro T; Yoshihisa A; Kunii H; Nakazato K; Ishida T; Suzuki O; Ohno S; Aiba T; Ohtani H; Takeishi Y
BMC Cardiovasc Disord; 2019 Dec; 19(1):298. PubMed ID: 31847799
[TBL] [Abstract][Full Text] [Related]
10. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
[TBL] [Abstract][Full Text] [Related]
11. Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity.
Tan CY; Chan PS; Tan H; Tan SW; Lee CJM; Wang JW; Ye S; Werner H; Loh YJ; Lee YL; Ackers-Johnson M; Foo RSY; Jiang J
J Transl Med; 2023 Oct; 21(1):690. PubMed ID: 37840136
[TBL] [Abstract][Full Text] [Related]
12. Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells.
Siu CW; Lee YK; Ho JC; Lai WH; Chan YC; Ng KM; Wong LY; Au KW; Lau YM; Zhang J; Lay KW; Colman A; Tse HF
Aging (Albany NY); 2012 Nov; 4(11):803-822. PubMed ID: 23362510
[TBL] [Abstract][Full Text] [Related]
13. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
[TBL] [Abstract][Full Text] [Related]
14. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
[TBL] [Abstract][Full Text] [Related]
15. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
Stallmeyer B; Koopmann M; Schulze-Bahr E
Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
[TBL] [Abstract][Full Text] [Related]
17. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.
Parks SB; Kushner JD; Nauman D; Burgess D; Ludwigsen S; Peterson A; Li D; Jakobs P; Litt M; Porter CB; Rahko PS; Hershberger RE
Am Heart J; 2008 Jul; 156(1):161-9. PubMed ID: 18585512
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
[TBL] [Abstract][Full Text] [Related]
19. The genetics of dilated cardiomyopathy: a prioritized candidate gene study of LMNA, TNNT2, TCAP, and PLN.
Hirtle-Lewis M; Desbiens K; Ruel I; Rudzicz N; Genest J; Engert JC; Giannetti N
Clin Cardiol; 2013 Oct; 36(10):628-33. PubMed ID: 24037902
[TBL] [Abstract][Full Text] [Related]
20. A novel deletion mutation accompanied by a point mutation in Lamin A/C gene: Screened from a dilated cardiomyopathy family.
Jia H; Sun Y; Yao W; Chen Z; Yang S; Wang C; Lu S
Perfusion; 2023 May; 38(4):826-836. PubMed ID: 35514053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
